Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab

JAMA Dermatol. 2023 Sep 1;159(9):1009-1011. doi: 10.1001/jamadermatol.2023.1417.

Authors

Yuta Koike¹, Takuya Takeichi², Norito Ishii³, Tomoka Waseda¹, Naoya Murayama¹, Masashi Akiyama², Hiroyuki Murota¹

Affiliations

¹ Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
² Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
³ Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.

PMID: 37466956
DOI: 10.1001/jamadermatol.2023.1417

No abstract available

Plain language summary

This case report describes a woman with severe dermatitis, multiple allergies, and metabolic wasting syndrome.

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis*
Humans
Hypersensitivity*
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized